Executive Orders and Federal Actions
Directs the Commissioner of the Food and Drug Administration to review and eliminate any duplicative or unnecessary requirements in regulations and guidance pertaining to the development of domestic pharmaceutical manufacturing within 180 days.
Requires agencies to identify at least 10 regulations to be repealed for each new regulation proposed or promulgated. Directs agencies to ensure total incremental cost of all new regulations for FY 2025, including repealed regulations, is less than $0.
The AHA is tracking the Executive Orders and Actions of the Trump White House that may be of interest to hospitals and health systems.